Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Latest Brian Kobilka Stories

2013-07-23 20:21:01

PALO ALTO, Calif., July 23, 2013 /PRNewswire-USNewswire/ -- ConfometRx is pleased to announce that the U.S. Patent and Trademark Office (USPTO) recently awarded ConfometRx Patent No. 8,470,561 entitled "GPCR comprising an IC2 insertion," which covers G protein coupled receptors (GPCRs) that have a stabilizing fusion in the second intracellular loop (IC2). Importantly, this patent broadly covers any GPCR that has a stable, folded protein insertion in its IC2 region, as well as crystals...

2013-03-27 16:27:45

PALO ALTO, Calif., March 27, 2013 /PRNewswire-USNewswire/ -- ConfometRx Research Foundation is pleased to announce the 2013 GPCR Workshop to be held at Hyatt Regency, Maui Dec 1-5, 2013. The Royal Swedish Academy of Sciences called global attention to the significance of G protein coupled receptors (GPCRs) by awarding the 2012 Nobel Prize in Chemistry to two pioneers in the field. GPCRs mediate the senses of sight, olfaction and taste, as well as the physiologic responses to the majority of...

2013-02-21 16:29:40

Innovative collaboration launched with ConfometRx, the GPCR structural biology company founded by Stanford University professor and Nobel Prize winner Brian Kobilka PALO ALTO, Calif., Feb. 21, 2013 /PRNewswire-USNewswire/ -- ConfometRx announced today that it has sealed a research agreement with UCB to enable the discovery of novel medicines addressing unmet medical need in Neuroscience. Under this two-year multi-target agreement UCB and ConfometRx will leverage structural biology to...

Nobel Prize In Chemistry Awarded To Two US Scientists
2012-10-10 13:55:53

redOrbit Staff & Wire Reports - Your Universe Online Groundbreaking research into how the protein receptors of cells detect and respond to external signals -- work that could lead to the development of better drugs to combat cancer and diabetes -- has earned two US scientists the 2012 Nobel Prize in Chemistry. Sixty-nine year old Robert Lefkowitz, a professor at Duke University Medical Center, and 57-year-old Brian Kobilka, a professor at Stanford University School of Medicine, were...

2012-02-29 13:45:00

SANTA CLARA, Calif., Feb. 29, 2012 /PRNewswire/ -- ConfometRx, a leader in G protein coupled receptor (GPCR) structural characterization and analysis, is pleased to announce that it has expanded its service offerings to include generating iterative crystal structures of new GPCR targets as well as any GPCRs whose structures have been solved using T4-lysozyme (T4-L) fusion technology, and agonist structures using antibodies or G proteins to stabilize active states. The T4-L technology was...

2010-01-07 13:41:43

Researchers at the Stanford University School of Medicine have taken an early step toward identifying a new approach to drug discovery that may eventually yield drugs with fewer side effects. In a study to be published online Jan. 7 in Nature, investigators led by senior author Brian Kobilka, MD, professor and chair of molecular and cellular physiology, found that largely neglected regions on key cell-surface proteins undergo minute changes in shape in response to drugs and thus could prove...